Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Improving Tolerance of Treatment of Pulmonary Mycobacterium Avium Complex Infections

Trial Profile

Improving Tolerance of Treatment of Pulmonary Mycobacterium Avium Complex Infections

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2013

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 17 Jan 2013 Planned end date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
    • 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top